CCA
STIM icon

Cruiser Capital Advisors’s Neuronetics STIM Stock Holding History

Cruiser Capital Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.6K Hold
48,900
– – 0.04% 41
2026
Q1 		$70.9K Hold
48,900
– – 0.03% 42
2025
Q4 		$67.5K Sell
48,900
-1,100
-2% -$2.3K 0.06% 44
2025
Q3 		$137K Hold
50,000
– – 0.14% 44
2025
Q2 		$175K Hold
50,000
– – 0.08% 37
2025
Q1 		$184K Buy
+50,000
New +$183K 0.25% 38

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cruiser Capital Advisors's STIM Position: Q2 2026 in Review

Cruiser Capital Advisors held its Neuronetics (STIM) position steady in Q2 2026 at 48,900 shares worth $63.6K. The position accounts for 0.04% of the portfolio, ranked #41.

Cruiser Capital Advisors first reported a position in STIM in Q1 2025 and has held it in 6 quarters since. The position peaked at $184K in Q1 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Cruiser Capital Advisors held 48,900 shares of Neuronetics worth $63.6K as of Q2 2026.
  • Cruiser Capital Advisors left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up 0.04% of Cruiser Capital Advisors's portfolio in Q2 2026, its #41 holding.
  • Cruiser Capital Advisors first reported a position in Neuronetics in Q1 2025 and has held it in 6 quarters since.
  • Cruiser Capital Advisors's Neuronetics position peaked at $184K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Cruiser Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.